Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibogaine pilot study for opioid dependence
NL-OMON40645Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ibogaine in opioid use disorder (OUD), sponsored by Radboud University Medical Center. Primary endpoints: Number of relapse, Subjective craving after detoxification and 1 more. Started Oct 2015; status: active, not recruiting.
02
Drugs
ibogaine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NL-OMON40645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40645.